Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
316M
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
108M
-
Shares change
-
-1.62M
-
Total reported value, excl. options
-
$655M
-
Value change
-
-$9.86M
-
Put/Call ratio
-
0.25
-
Number of buys
-
94
-
Number of sells
-
-52
-
Price
-
$6.06
Significant Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q1 2024
185 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q1 2024.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 108M shares
of 316M outstanding shares and own 34.21% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (13.7M shares), TPG GP A, LLC (12.3M shares), Fosun International Ltd (12.3M shares), Rubric Capital Management LP (9.54M shares), BlackRock Inc. (9.16M shares), CITADEL ADVISORS LLC (5.07M shares), NEUBERGER BERMAN GROUP LLC (3.92M shares), DIMENSIONAL FUND ADVISORS LP (3.64M shares), STATE STREET CORP (2.94M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.77M shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.